BRIEF published on 12/27/2024 at 07:35, 3 months 28 days ago Sensorion Completes Enrollment for Audiogene Phase 1/2 Trial Gene Therapy Sensorion Hearing Loss SENS-501 Audiogene Trial
PRESS RELEASE published on 12/27/2024 at 07:30, 3 months 28 days ago Inside Information / Other news releases Sensorion completes enrollment of the first cohort in the Audiogene Phase 1/2 gene therapy clinical trial, targeting infants with hearing loss disorders Gene Therapy Clinical Trial Sensorion Hearing Loss Disorders Audiogene
BRIEF published on 12/18/2024 at 07:35, 4 months 6 days ago Sensorion Reports Positive Preliminary Results for SENS-501 Gene Therapy Clinical Trial SENS-501 Congenital Deafness Biotechnological Innovation
PRESS RELEASE published on 12/18/2024 at 07:30, 4 months 6 days ago Inside Information / Other news releases Sensorion reports positive safety data and behavioral changes in toddlers from the Audiogene Phase 1/2 Gene Therapy Clinical Trial. Plans KOL event in 2025 for further discussion Gene Therapy Clinical Trial Sensorion Hearing Loss Audiogene
BRIEF published on 11/06/2024 at 07:35, 5 months 18 days ago Sensorion to Join Key Investor Conferences in November 2024 Biotechnology Investor Conferences Sensorion Hearing Loss Therapies Gene Therapy Development
PRESS RELEASE published on 11/06/2024 at 07:30, 5 months 18 days ago Inside Information / Other news releases Sensorion to participate in upcoming investor conferences in November 2024, including Stifel Healthcare Conference and LifeSci Capital & Sofinnova Partners Summit Biotechnology Investor Conferences Clinical-stage Sensorion Hearing Loss Disorders
BRIEF published on 09/20/2024 at 07:35, 7 months 4 days ago Sensorion Unveils Promising New Clinical Advances Biotechnology Clinical Trials Gene Therapy Hearing Loss Small Molecule
PRESS RELEASE published on 09/20/2024 at 07:30, 7 months 4 days ago Inside Information / Other news releases Sensorion announces positive clinical data on gene therapy and small molecule programs at World Congress of Audiology, Paris. Details by key medical professionals Clinical Data Gene Therapy Sensorion World Congress Of Audiology Small Molecule
BRIEF published on 09/18/2024 at 07:35, 7 months 6 days ago Sensorion Reports First Half 2024 Financial Results and Clinical Advances Clinical Trials Gene Therapy 2024 Financial Results Sensorion Hearing Loss Therapies
PRESS RELEASE published on 09/18/2024 at 07:30, 7 months 6 days ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report Sensorion reports 2024 first half results including progress on SENS-501 and SENS-401 programs. Cash position strong at €87m. Future milestones and financial highlights outlined Sensorion Hearing Loss SENS-401 SENS-501 2024 Results
Published on 04/24/2025 at 09:05, 51 minutes ago Nano One 2025 Annual General Meeting of Shareholders
Published on 04/24/2025 at 00:00, 9 hours 56 minutes ago Sekur Private Data Retains Stockhouse for International Awareness Campaign
Published on 04/23/2025 at 23:00, 10 hours 56 minutes ago Electrovaya Announces Date for Q2-2025 Financial Results & Conference Call
Published on 04/23/2025 at 23:00, 10 hours 56 minutes ago NioCorp to Host Webcast Update on the Elk Creek Critical Minerals Project
Published on 04/24/2025 at 09:30, 26 minutes ago BEAUTY&YOU by The Shilla Duty Free Unveils the 1st Monochromatic Art Style 'Shilla Fragrance Journey' at Hong Kong International Airport
Published on 04/24/2025 at 07:00, 2 hours 56 minutes ago Thales reports its order intake and sales for the first quarter of 2025
Published on 04/24/2025 at 07:00, 2 hours 56 minutes ago 2025 first quarter sales: €235.5m (+10.7%). Solid growth
Published on 04/23/2025 at 18:39, 15 hours 17 minutes ago Derichebourg announces its financial calendar for 2024/2025 financial year
Published on 04/23/2025 at 18:17, 15 hours 39 minutes ago Disclosure of trading in own shares between April 14th and April 17th, 2025
